7 August 2018 - 2019 National Preferred Formulary includes low list price medications in high-cost categories.

Despite drug maker promises to limit price increases, their ongoing efforts to game the system by delaying generic competition, blocking safe and effective biosimilars and refusing to eliminate list price increases are the main reasons medication remains unaffordable for many people. 

Today, Express Scripts is taking action to address these tactics by exposing opportunities within our National Preferred Formulary that will further improve affordability and access for payers and patients.

Read Express Scripts article